A retrieval device for removing early-stage bladder tumors
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests a special device that helps remove bladder tumors in one piece during a standard procedure. It aims to make the removal safer and more complete for early-stage bladder cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a suspected early-stage bladder tumor (not grown into the muscle layer).
- The largest tumor is 5 cm or smaller.
- You are scheduled to have the tumor removed through the urethra as a single piece.
- You have not had a bladder tumor removed in the last 2 years.
- You do not have an active urinary tract infection at the time of surgery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a redesigned surgical instrument used during bladder tumor removal, to see if it can improve how the removed tissue samples are collected. It may help future patients by supporting better study of bladder tissue during cancer care.
This trial tests a new robotic system to remove bladder tumors in one piece (en-bloc resection) for people with early-stage, non-muscle invasive bladder cancer. It may offer a more precise surgical option for eligible patients.
This trial tests whether artificial intelligence (AI) can help guide surgeons during a procedure called TURBT to remove early-stage bladder cancer. The goal is to see if this technology improves the removal of cancer while potentially reducing risks.
This study tests whether using a special blue light (photodynamic diagnosis) during bladder surgery helps remove all the cancer more completely. It's for people having their first surgery for a medium-sized bladder tumor.
This study looks at tumor and blood samples from people with muscle-invasive bladder cancer to find markers that help predict how the disease will progress. It aims to improve personalized treatment for those with this specific stage of bladder cancer.
This study looks at whether removing nearby lymph nodes during radical cystectomy (bladder removal) improves outcomes for people with high-risk non–muscle-invasive bladder cancer. It may help doctors choose the best surgical approach to reduce the chance of cancer coming back.
Hear when a new Bladder Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.